Find

Department of Clinical Medicine

HemeLab

Publications

Sort by: Date | Author | Title

Sørensen, J. F., Kristensen, D. T., Ørskov, A. D., Hansen, D. L., Aggerholm, A., Grønbæk, K., Roug, A. S. & Ludvigsen, M. (2025). A Danish nationwide population-based cohort study on acute myeloid leukemia with RUNX1::RUNX1T1 - Real-world outcomes and clinicopathological characteristics. Blood Cancer Journal, 15(1), Article 171. https://doi.org/10.1038/s41408-025-01377-8

Pedersen, M. N., Hybel, T. E., Bjerre, J. H., Hammer, A. S. B., Bohn, A. B., Bill, M., Rosenberg, C. A. & Ludvigsen, M. (2025). High-Efficiency Enrichment of Megakaryocytes and Identification of Micromegakaryocytes from Human Bone Marrow by Imaging Flow Cytometry. Cells, 14(8), Article 588. https://doi.org/10.3390/cells14080588

Andersen, M. D., Enemark, M. H., Lauridsen, K. L., Hamilton-Dutoit, S. J., Starklint, J., d’Amore, F., Ludvigsen, M. & Kamper, P. (2025). Lymph node transcriptomic profiles suggest susceptibility to bleomycin-induced pulmonary toxicity in classic hodgkin lymphoma. Scientific Reports, 15(1), Article 30273. https://doi.org/10.1038/s41598-025-16218-8

Andersen, M. D., Wolter, K., Enemark, M. H., Lauridsen, K. L., Hamilton-Dutoit, S. J., Starklint, J., d’Amore, F., Ludvigsen, M., Honoré, B. & Kamper, P. (2025). Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity. Leukemia & Lymphoma, 66(4), 656-667. https://doi.org/10.1080/10428194.2024.2434170

Hemmingsen, J. K., Enemark, M. B. H., Sørensen, E. F., Dohrmann, C., Lauridsen, K. L., Hamilton-Dutoit, S. J., Kridel, R., Honoré, B. & Ludvigsen, M. (2025). Proteomic Profiling of Limited-Stage Follicular Lymphoma Reveals Differentially Expressed Proteins Linked to Disease Progression Post-Radiation Therapy. International Journal of Molecular Sciences (Online), 26(19), Article 9306. https://doi.org/10.3390/ijms26199306

Andersen, M. D., Wolter, K., Enemark, M. B. H., Pedersen, M. A., Gormsen, L. C., Lauridsen, K. L., Starklint, J., Hamilton-Dutoit, S. J., d'Amore, F., Ludvigsen, M., Honoré, B. & Kamper, P. (2025). Proteomic Profiling of Lymph Nodes Differentiates Classic Hodgkin Lymphoma With and Without Skeletal Involvement. European Journal of Haematology, 114(1), 173-185. https://doi.org/10.1111/ejh.14326

Haraldsdóttir, H., Brøndum, R. F., Enemark, M. B. H., Honoré, B., Ludvigsen, M., Aboo, C., Stensballe, A., Jørgensen, J. M., Due, H. & Dybkær, K. (2025). Proteomic Study of Diffuse Large B-Cell Lymphoma Identifying Proteins Associated with R-CHOP Response. Biomedicines, 13(11), Article 2709. https://doi.org/10.3390/biomedicines13112709

Hemmingsen, J. K., Enemark, M. H., Pedersen, A. K., Sørensen, E. F., Lauridsen, K. L., Løhde, J. B., d’Amore, F., Hamilton-Dutoit, S. J., Bjerre, M. & Ludvigsen, M. (2025). Reduced Activity of Soluble Fibroblast Activation Protein (sFAP) Represents a Biomarker of Aggressive Disease in Lymphoid Malignancies. International Journal of Molecular Sciences , 26(23), Article 11248. https://doi.org/10.3390/ijms262311248

Sorensen, E. F., Hybel, T. E. & Ludvigsen, M. (2025). Response to correspondence piece on 'Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes'. AIDS, 39(4), 481-481. https://doi.org/10.1097/QAD.0000000000004139

Andersen, M. D., Wolter, K., Enemark, M. H., Pedersen, M. A., Gormsen, L. C., Lauridsen, K. L., Starklint, J., Hamilton-Dutoit, S. J., d'Amore, F., Ludvigsen, M. & Kamper, P. (2025). Tumor-associated macrophages: potential role in skeletal involvement in classic Hodgkin lymphoma. Journal of Pathology: Clinical Research, 11(4), Article e70038. https://doi.org/10.1002/2056-4538.70038

MacManus, M. P., Seymour, J. F., Tsang, H., Fisher, R., Keane, C., Sabdia, M. B., Law, S. C., Gunawardana, J., Nath, K., Kazakoff, S. H., Marques-Piubelli, M. L., Duenas, D. E., Green, M. R., Roos, D., O'Brien, P., McCann, A., Tsang, R., Davis, S., Christie, D. ... Tobin, J. W. D. (2024). Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma. EBioMedicine, 110, Article 105468. https://doi.org/10.1016/j.ebiom.2024.105468

Urbonavicius, S., Srinanthalogen, R., Sandermann, J., Valius, M., Kaupinis, A. & Ludvigsen, M. (2024). A novel view to varicose veins pathogenesis: Proteomic profiling suggests a pivotal role of extracellular matrix degradation. Phlebology, 39(1), 20-28. https://doi.org/10.1177/02683555231206891

Hybel, T. E., Sørensen, E. F., Enemark, M. H., Hemmingsen, J. K., Simonsen, A. T., Lauridsen, K. L., Møller, M. B., Pedersen, C., Pedersen, G., Obel, N., Larsen, C. S., d'Amore, F., Hamilton-Dutoit, S., Stougaard, M., Vase, M. Ø. & Ludvigsen, M. (2024). Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes. AIDS, 38(14), 1897-1906. https://doi.org/10.1097/QAD.0000000000003996

Rosenberg, C. A., Rodrigues, M. A., Bill, M. & Ludvigsen, M. (2024). Comparative analysis of feature-based ML and CNN for binucleated erythroblast quantification in myelodysplastic syndrome patients using imaging flow cytometry data. Scientific Reports, 14(1), Article 9349. https://doi.org/10.1038/s41598-024-59875-x

Holst, J. M., Pedersen, M. B., Enemark, M. B., Hansen, M. C., Noerhave, P. R., Plesner, T. L., Frederiksen, H., Moeller, M. B., Hamilton-Dutoit, S. J., Noergaard, P., Mortensen, B. K., Ommen, H. B., Stentoft, J., Tam, W., Ludvigsen, M., Chan, W. C., Birkbak, N. J., Inghirami, G. & d’Amore, F. (2024). Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma. Haematologica, 109(12), 4067-4072. https://doi.org/10.3324/haematol.2023.283798

Enemark, M. H., Wolter, K., Hybel, T. E., Andersen, M. D., Sørensen, E. F., Hindkaer, L. M., Lauridsen, K. L., Madsen, C., Plesner, T. L., Hamilton-Dutoit, S., Honoré, B. & Ludvigsen, M. (2024). Differential tumor protein expression at follicular lymphoma diagnosis reveals dysregulation of key molecular pathways associated with histological transformation. Scientific Reports, 14(1), Article 29962. https://doi.org/10.1038/s41598-024-81693-4

Shelton, V., Detroja, R., Liu, T., Isaev, K., Silva, A., Passerini, V., Bakhtiari, M., Calvente, L., Hong, M., He, M. Y., Modi, S., Hershenfeld, S. A., Ludvigsen, M., Madsen, C., Hamilton-Dutoit, S., d’Amore, F. A., Brodtkorb, M., Johnson, N. A., Baetz, T. ... Kridel, R. (2024). Identification of genetic subtypes in follicular lymphoma. Blood Cancer Journal, 14(1), Article 128. https://doi.org/10.1038/s41408-024-01111-w

Enemark, M. B. H. (2024). Identifying predictive biomarkers of histological transformation in follicular lymphoma: unravelling biological differences as means for patient-specific risk stratification. [PhD dissertation, Aarhus University].

Hybel, T. E., Jensen, S. H., Rodrigues, M. A., Hybel, T. E., Pedersen, M. N., Qvick, S. H., Enemark, M. H., Bill, M., Rosenberg, C. A. & Ludvigsen, M. (2024). Imaging Flow Cytometry and Convolutional Neural Network-Based Classification Enable Discrimination of Hematopoietic and Leukemic Stem Cells in Acute Myeloid Leukemia. International Journal of Molecular Sciences , 25(12), Article 6465. https://doi.org/10.3390/ijms25126465

Enemark, M. H., Jensen, M. L., Andersen, M. D., Plesner, T. L., Hamilton-Dutoit, S. & Ludvigsen, M. (2024). Impact of the Immune Landscape in Follicular Lymphoma: Insights into Histological Transformation in the Rituximab Era. Cancers, 16(20), Article 3553. https://doi.org/10.3390/cancers16203553

Displaying results 1 to 20 out of 128

1

Revised 11.09.2025

-

Maja Ludvigsen